At SCF Biotech, we do not stimulate the immune system blindly.
We restore immune identity through biologically gated sequencing.
PRISM™ (Platform for Regulated Immune Structural Modulation) is a mechanistic, biomarker-driven therapeutic architecture designed to repair immune collapse across post-viral disease, oncology-associated lymphopenia, and aging-related immune decline.
Unlike conventional immune therapies that escalate dose when results falter, PRISM enforces tiered biological readiness — ensuring that restorative signals are delivered only when the system is structurally and metabolically prepared to receive them .
The Core Principle
Immune restoration is hierarchical.
Escalation is earned biologically — not scheduled temporally .
Immune identity cannot regenerate in an unstable environment.
PRISM corrects the environment first.
The PRISM™ Five-Tier Architecture
PRISM is built on a universal immune collapse axis that applies across indications .
Tier | Biological Domain | What Must Be Stabilized |
Tier I | Metabolic & Redox Stability | Energy availability, mitochondrial competence |
Tier II | Inflammatory Signal Control | Cytokine noise and innate overactivation |
Tier III | Structural / Stromal Niche Readiness | Bone marrow & lymphoid ECM integrity |
Tier IV | Epigenomic & Lineage Readiness | Receptor fidelity and gene accessibility |
Tier V | Lineage Restoration | Durable immune identity regeneration |
Each tier has:
- Entry criteria
- Exit criteria
- Escalation rules
- Rollback conditions
No tier may be skipped.
Why Sequencing Matters
Immune restoration fails when signals arrive before the system is ready to decode them.
PRISM enforces stepwise correction because:
- Structural damage cannot be corrected by cytokines
- Inflammatory noise corrupts regenerative signals
- Epigenomic exhaustion blocks lineage renewal
For example, IL-7–mediated lineage restoration is powerful but high-risk. It may only proceed after structural and inflammatory permissivity are confirmed .
This is not combination dosing.
This is conditional therapeutic sequencing.
Biomarker-Gated Escalation
PRISM does not escalate by calendar or protocol habit.
Progression between tiers requires:
- Structural normalization
- Stable inflammatory profile
- No aberrant proliferation signals
- Disease-specific control maintained
If instability appears, the system rolls back to the lowest unstable tier — never dose escalation .
This design enhances:
- Safety
- Regulatory interpretability
- Signal durability
Cross-Disease Platform Strategy
PRISM scales across immune collapse indications while respecting biological boundaries .
Oncology-Associated Lymphopenia
- High translational clarity
- Structural repair → lineage restoration
- Strongest non-infectious expansion pathway
Post-Viral Immune Collapse
- Strict biomarker gating
- Restoration only after viral clearance and inflammatory containment
Aging-Associated Immunosenescence
- Investigational, tightly controlled exploration
PRISM prevents indication-driven misuse by enforcing tier-based biological truth .
What Makes PRISM Different
Conventional Approach | PRISM™ Platform |
Dose escalation for non-response | Rollback to unstable tier |
Concurrent combination therapy | Conditional, stepwise sequencing |
Inflammation tolerated during restoration | Inflammation must be neutralized first |
Structure ignored | Structural priming required |
Fixed protocol timing | Biomarker-gated progression |
PRISM integrates:
- Mechanistic logic
- Structural biology
- Epigenomic permissivity
- Safety-first cytokine deployment
All structured for IND, DSMB, and FDA interpretability .
Our Strategic Vision
We are building a platform where:
- Immune restoration is predictable
- Cytokine therapies are constrained and controlled
- Structural repair precedes activation
- Safety is engineered into sequencing logic
PRISM is not a single drug.
It is a regulatory-ready immune restoration system.
SCF Biotech
Sequenced. Gated. Restorative.
We do not push the immune system forward.
We prepare it — and then restore it — when biology says it is ready.